FDA Issues Draft Guidance for Conducting Clinical Trials With Psychedelic SubstancesJun 27, 2023 12:00:00 AM
Non-White Patients May Be More Likely to Be Excluded From Alzheimer’s Disease TrialsJul 7, 2021 12:00:00 AM
